ArticleOphthalmology. Glaucoma
The Validity of the Distress Thermometer in Patients with Primary Open-Angle Glaucoma.
Article in Ophthalmology. Glaucoma. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with Glaucoma.medRxiv : the preprint server for health sciences · 2026Article
- Design and Validation of an AI-Assisted Sequential Screening Framework for Psychological Distress in Glaucoma.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo validate the Distress Thermometer (DT) as a screening tool for psychosocial distress in primary open-angle glaucoma (POAG) patients and determine optimal cutoff score for clinical use.
designA clinic-based cross-sectional study.
participantsThree hundred POAG patients without recent glaucoma surgery within the past 6 months were recruited from Duke Eye Center clinics between September 2022 and August 2023.
methodsParticipants completed the DT, Hospital Anxiety and Depression Scale (HADS), Self-Efficacy for Managing Chronic Disease 6-item scale, Modified Medical Outcomes Study Social Support Survey 8-item scale, and National Eye Institute Visual Functioning Questionnaire 9-item scale prior to clinic visit. Receiver operating characteristic analysis compared DT cutoff scores (4, 5, and 6) against HADS thresholds for overall distress, anxiety (HADS-A), and depression (HADS-D) subscales. Sensitivity, specificity, positive/negative predictive values, and area under the curve were calculated. Associations between distress and demographic/clinical variables were also explored. Comparison of patient characteristics was conducted between groups correctly and incorrectly classified by the DT relative to the HADS.
main outcome measuresValidity of DT in detecting clinically significant distress, as determined by HADS, with secondary outcomes of patient acceptability of DT and factors associated with distress.
resultsThe optimal DT cutoff was 5 for detecting overall distress (HADS ≥15; sensitivity 0.78, specificity 0.76) and depression (HADS-D ≥8; sensitivity 0.84, specificity 0.73), while a cutoff of 4 best identified anxiety (HADS-A ≥7; sensitivity and specificity both 0.75). Area under the curve values were 0.83 to 0.84, indicating strong discriminative ability. Distress Thermometer negatively correlated with age, social support, self-efficacy, vision-related quality of life, intraocular pressure of the better eye, and standard automated perimetry mean deviation of the worse eye. Distress Thermometer was significantly associated with sex, marital status, income, and employment. Discrepancies between DT and HADS classification were linked to sex, distress, and social support. Patients found the DT highly acceptable (92% easy to complete; 88% not bothered by the question).
conclusionsThe DT is a valid, reliable, and acceptable screening tool for psychological distress in POAG patients. Its brevity and ease of use supports implementation into routine glaucoma care, enabling early identification and intervention to improve outcomes and quality of life for distressed POAG patients. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.